Drug Search Results
More Filters [+]

ASP-7373

Alternative Names: asp-7373, asp7373, asp 7373
Latest Update: 2017-09-29
Latest Update Note: Clinical Trial Update

Product Description

recombinant influenza HA vaccine (H5N1)

Mechanisms of Action: Vaccine

Novel Mechanism: No

Modality: Vaccine

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: UMN Pharma
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for ASP-7373

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Influenza, Human

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

7373-CL-0106

P2

Completed

Influenza, Human

2011-12-01

Recent News Events

Date

Type

Title